CPI-17调控血管平滑肌表型对动脉粥样硬化形成的影响

来源 :山东大学学报(医学版) | 被引量 : 0次 | 上传用户:HOHO333
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的研究CPI-17(PKC-potentiated protein phosphatase inhibitory protein-17)通过诱导血管平滑肌细胞表型改变影响动脉粥样硬化形成的作用。方法载脂蛋白E基因敲除(ApoE-knockout)小鼠经颈动脉套管术诱导形成动脉粥样斑块,以野生型C57BL/6小鼠为对照,分离颈动脉并提取总RNA,采用实时荧光定量PCR技术对比检测斑块组织与对照小鼠颈动脉中CPI-17及血管平滑肌细胞收缩功能相关蛋白-平滑肌肌球蛋白重链(sm-MHC)、α-肌动蛋白(α-actin)的mRNA水平。然后分别用50mg/L氧化型低密度脂蛋白(ox-LDL)刺激及乏氧环境下培养作用于小鼠平滑肌细胞系MOVAS细胞,实时荧光定量PCR检测两种刺激条件下CPI-17表达的变化。结果 ApoE-knockout小鼠粥样斑块平滑肌细胞的CPI-17mRNA水平及sm-MHC、α-actin显著低于C57BL/6小鼠,ox-LDL刺激及乏氧培养的MOVAS细胞的CPI-17表达水平显著降低(P均<0.05)。结论 ox-LDL刺激及乏氧培养使MOVAS细胞的CPI-17表达水平降低,可能通过调控血管平滑肌细胞的收缩特性参与动脉粥样硬化的发生。 Objective To investigate the effect of CPI-17 (PKC-potentiated protein phosphatase inhibitory protein-17) on the formation of atherosclerosis by inducing vascular smooth muscle cell phenotype changes. Methods ApoE-knockout mice were induced to form atherosclerotic plaque by carotid artery cannulation. The wild type C57BL / 6 mice were used as control. The carotid artery was isolated and the total RNA was extracted. Fluorescent quantitative PCR was used to detect the expression of contractile-related proteins-sm-MHC, α-actin in CPI-17 and vascular smooth muscle cells in carotid artery of plaque tissue and control mice. MRNA level. Then, the cells were cultured in ox-LDL (50mg / L ox-LDL) and cultured in hypoxic environment, respectively. The changes of CPI-17 expression were detected by real-time fluorescence quantitative PCR . Results CPI-17 mRNA level and sm-MHC, α-actin in ApoE-knockout mice atherosclerotic plaque cells were significantly lower than those in C57BL / 6 mice, ox-LDL stimulated and hypoxia-cultured MOVAS cells The levels were significantly lower (P <0.05). Conclusion Ox-LDL stimulation and hypoxia culture can decrease the expression of CPI-17 in MOVAS cells, which may be involved in the development of atherosclerosis by regulating the contractile properties of vascular smooth muscle cells.
其他文献
期刊
期刊
期刊
目的:观察辛伐他汀与微粒化非诺贝特及二者联合治疗混合性高脂血症的疗效及安全性分析。方法:将150例混合性高脂血症患者,随机分为辛伐他汀(A)组、非诺贝特(B)组和联合治疗(C)组
目的:探讨负压闭式引流治疗糖尿病足合并溃疡的临床疗效和并发症情况。方法:选取2013年2月~2014年2月来我院治疗的糖尿病足合并溃疡患者58例,其中男38例,女20例,采用负压闭式引流
目的:研究对甲状腺功能亢进症患者采取不同疗程碘131治疗的临床效果。方法:将我院2012年2月~2013年3月90例甲亢患者以抽签法随机分为观察组与对照组,2组均采取常规剂量治疗,3个月
目的:分析HBV血清标志物与HBV-DNA定量检测结果。方法采用ELISA检测302份乙肝病毒血清标志物,同时FQ-PCR法定量检测HBV-DNA,对比检测结果。结果血清标志物I(HBeAg、HBcAb、HBsAg)
目的:对奥曲肽联合泮托拉唑治疗肝硬化并上消化道出血的临床治疗效果进行观察。方法:选取从2011年2月~2014年2月收治的126位患有肝硬化并上消化道出血的患者,随机的将所有患者分
目的:系统分析CT在胰腺及肾上腺闭合性损伤患者中的临床诊断效果。方法:所有研究对象在进行CT检查之前半小时内将300ml的2%泛影葡胺溶液1次性口服,同时,在进行检查前再口服300ml